# Effects of Intravitreal Ranibizumab for Macular Edema With Nonproliferative Diabetic Retinopathy

> **NCT02834663** · PHASE4 · COMPLETED · sponsor: **Wonkwang University Hospital** · enrollment: 25 (actual)

## Conditions studied

- Nonproliferative Diabetic Retinopathy

## Interventions

- **DRUG:** Lucentis

## Key facts

- **NCT ID:** NCT02834663
- **Lead sponsor:** Wonkwang University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2019-02
- **Final completion:** 2019-12
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2020-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02834663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02834663, "Effects of Intravitreal Ranibizumab for Macular Edema With Nonproliferative Diabetic Retinopathy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02834663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*